Recent studies have shown that this third alpha-class hypoxia inducible factor subunit can modulate oxidative stress and mitigate ROS-induced damage under hypoxic conditions in chronic obstructive pulmonary disease, by influencing pathways involved in redox biology, such as the activation of GPX4 [66]. Here, GPX4 is linked to chronic obstructive pulmonary disease.